Overall, very well written review of a large single institution experience with esophagectomy in obese population.
Discussion is too longquoting detailed results from numerous studies.
GENERAL COMMENTS
This retrospective cohort study of over 500 patients from the high volume Moffitt Cancer Centre over a 16.5 year period from 1994 has shown that obese patients who undergo oesophagogastrectomy for cancer have similar short term outcomes compared with patients of normal BMI. Obese patients were on average 3 years younger and had a higher proportion of diabetes compared with patients of normal BMI. In the multivariate analysis, obesity was not associated with increased morbidity and mortality. Overall, the article is well written and the results support their conclusions. However, the novelty of this paper is questionable as numerous reports have shown similar findings. This paper does not add significantly to the body of literature on this subject of obesity in oesophagogastric surgery. Overall, very well written review of a large single institution experience with esophagectomy in obese population.
REVIEWER
In contrast to multiple other groups, no significant differences were noted in operative morbidity for patients with increaed BMI. As authors note, their data is somewhat limited in the number of cases with BMI>40, however overall this does not limit the clinical importance of this manuscript.
The authors mentioned a few variables that may have effected outcome, such as time period during which the surgeries were performed. They should also discuss their choice of operative approach (transthoracic, transhiatal, robotic) and how that may have been associated with BMI. Thank you for the comment.
While it is conceivable that there may be a difference in outcomes with more patients undergoing a MIE, review of our data reveals no differences in those with elevated BMI undergoing MIE compared to those that do not. With the same amounts in each group undergoing MIE shouldn't play a huge role in overall outcomes.
The following was added to the manuscript regarding surgery selection:
The choice of surgical technique is based on tumor location and stage as well as the surgeon's and patient's preference. Select patients underwent MIE, however there were no pre-selection bias based upon BMI and the decision as to the type of surgery was based upon individual surgeons practice.
Reviewer: Mr Wyn Lewis Consultant Upper GI Surgeon University Hospital of Wales Cardiff, Wales, UK.
Competing interests: None
Can the authors justify using means and ANOVA tests for differences in pre-operative risk factors and complications? They are assuming the data to be parametric. Perhaps medians and the Mann-Whitney U test would be more appropriate if the data is non-parametric.
Thank you for the comment, we have investigated the data previously and found the data to be parametric assuming normal distribution with homogeneous variances and therefore the means and ANOVA tests are appropriate.
The table of complications is too long.
Thank you for the comment, as the reviewer is aware, esophagectomy patients have multiple complications and we attempted to elucidate the most frequent complications which are most often reported.
We have shortened the discussion. Thank you for the comment.
This retrospective cohort study of over 500 patients from the high volume Moffitt Cancer Centre over a 16.5 year period from 1994 has shown that obese patients who undergo oesophagogastrectomy for cancer have similar short term outcomes compared with patients of normal BMI. Obese patients were on average 3 years younger and had a higher proportion of diabetes compared with patients of normal BMI. In the multivariate analysis, obesity was not associated with increased morbidity and mortality. Overall, the article is well written and the results support their conclusions. However, the novelty of this paper is questionable as numerous reports have shown similar findings. This paper does not add significantly to the body of literature on this subject of obesity in oesophagogastric surgery. Authors should state consent of ethics committee in using patient data for research purposes Thank you. This was added to the methods.
The authors discuss a very relevant problem which rises in esophageal cancer patients throughout the western world and is therefore a very relevant subject.
Major comments:
The subject is not new and two recent studies, which are missing in the reference list have looked at similar or larger cohorts of patients with similar results as the present study.
(Grotenhuis World J Surg 2010 and Blom Ann Surg Oncol 2012).
We have added in the discussion and to the manuscript Results of these studies should be discussed and compared to the present study.
Although the results are not new, the message coming from a large US tertiary center might still be relevant.
Local Medical ethical committee's approval should be stated.
We have included a statement in the methods. Thank you for the comment.
The title suggests this is a review of a prospective database. In the methods section, however retrospective chart review is mentioned (solely by experienced clinicians). The authors should state what method was used. If this was a retrospective study 'prospective' should be omitted from the title.
Thank you for the comment we have changed the title accordingly.
Body Mass Index and Peri-Operative Complications after Esophagectomy for Adenocarcinoma: A Systematic Database Review
To compare morbidity of the present series with other international series morbidity should be clearly defined. None of the complications mentioned in the study are defined. Please add a list to the methods section defining the all complications. Furthermore severity of complications should be taken into account. Dindo's classification for example shows classification in severity of morbidity. This should be added to the results.
Thank you for the comment, the following is listed in the methods.
All complications from surgery to discharge from the hospital were investigated. Respiratory failure was defined as the requirement for mechanical ventilation more than 24 hours after surgery. Extended ICU was defined as more than 2 days in the ICU post esophagectomy. The diagnosis of pneumonia required positive sputum cultures or clear clinical and radiographic evidence of consolidation. Major pulmonary complications for the purpose of this analysis were defined as pneumonia, pleural effusion (as evidence on chest x-ray), pulmonary embolus (as diagnosed by VQ scan or spiral CT of the chest), and respiratory failure. Anastomotic leak was diagnosed by evidence of radiographic imaging via upper gastrointestinal series (UGI) or CT scan. Mortality was defined as any death within 30 days of esophagectomy.
From 709 patients in the database only 540 patients were included in the study. It should be stated in the results section or in a flow chart for what reason patients were excluded (missing data? sqaumous cell carcinoma?).
Thank you for the comment.
This query was strictly for adenocarcinoma patients which represents our most often treated patient population and more often present with higher BMI. In addition we only included patients that had the variables recorded and excluded if they had missing data.
The following was added Patients were excluded if they did not have a cancer diagnosis, had a diagnosis of squamous cell carcinoma, or in which data was missing.
Minor comment
It is unclear what surgical type of resection was used in the trans thoracic open and laparoscopic group (ie Ivor Lewis or McKeown). please state this in the methods section or in table.
The following has been added to the methods.
MIE's were performed via a transhiatal, transthoracic (Ivor Lewis) or robotic (transthoracic Ivor Lewis) approach. The open operations were most often performed via transthoracic (Ivor Lewis)technique. The choice of surgical technique is based on tumor location and stage as well as the surgeon's and patient's preference. Select patients underwent MIE, but the decision as to surgery type was made irrespective of BMI and uniformly on an individual surgeon's practice and expertise.
Would you be willing to share your data?
We would be willing to share our data in collaboration.
